Friday, July 10, 2026

Drug profile · INN

paracetamol

paracetamol (PHARMACY CARE PARACETAMOL) is a anandamide amidohydrolase inhibitor. Associated with Lacuna Pharma Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 73
News articles 0
Drug details — paracetamol

Quick answer

paracetamol (PHARMACY CARE PARACETAMOL) is a anandamide amidohydrolase inhibitor. Associated with Lacuna Pharma Pty Ltd.

Key facts

INN paracetamol
Brand PHARMACY CARE PARACETAMOL
Mechanism Anandamide amidohydrolase inhibitor
Target Fatty-acid amide hydrolase 1

Mechanism of action

Anandamide amidohydrolase inhibitor

Primary target: Fatty-acid amide hydrolase 1

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. 20200041 Phase 3 · Amgen · Extensive stage small cell lung cancer (ES-SCLC)
  2. 20230016 Phase 3 · Amgen · Limited-Stage Small-Cell Lung Cancer (LS SCLC)
  3. 299IG301 Phase 3 · Biogen · IgA nephropathy
  4. BN42082 Phase 3 · HOFFMANN-LA ROCHE · Relapsing Multiple Sclerosis (MS)
  5. BN42083 Phase 3 · HOFFMANN-LA ROCHE · Primary Progressive Multiple Sclerosis (PPMS)
  6. CA41705 Phase 3 · HOFFMANN-LA ROCHE · Lupus Nephritis (LN)
  7. CT-P13 3.11 Phase 3 · Celltrion Healthcare Australia · Rheumatoid arthritis
  8. EFC15992 Phase 3 · Sanofi-Aventis U.S · Plasma cell myeloma

Related & competitor drugs

  1. acetaminophen Cyclooxygenase inhibitor

Frequently asked questions

What is paracetamol?

paracetamol (PHARMACY CARE PARACETAMOL) is a anandamide amidohydrolase inhibitor. Associated with Lacuna Pharma Pty Ltd.

What is the brand name for paracetamol?

PHARMACY CARE PARACETAMOL is a marketed brand name for paracetamol. Check FDA Drugs@FDA for the current US label holder and prescribing information.